Comparison of urinary free beta (hCG) and beta-core (hCG) in prenatal screening for chromosomal abnormalities

Prenatal Diagnosis

Volumn 18, Issue 9, 1998, Pages 893-900

  Hallahan, Terrence W ^a   Krantz, David A ^a   Tului, Lucia ^b   Alberti, Ezio ^b   Buchanan, Philip D ^c   Orlandi, Francesco ^d   Klein, Victor ^e   Larsen Jr , John W ^f   Macri, James N ^a  

^a NTD Laboratories   (United States)

^b UNIVERSITY OF MILAN   (Italy)

^c GeneCare Medical Genetics Center   (United States)

^d Centro di Diagnosi Prenatale   (Italy)

^e NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^f GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Beta core (hCG); Down syndrome screening; Free beta (hCG); Maternal urine

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; DOWN SYNDROME; EMBRYO; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PRENATAL SCREENING; PRIORITY JOURNAL; TRISOMY 18; URINALYSIS;

CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 18; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; GESTATIONAL AGE; HUMANS; PAPER; PREGNANCY; PRENATAL DIAGNOSIS; REFERENCE VALUES; TRISOMY;

EID: 0031754944     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199809)18:9<893::AID-PD362>3.0.CO;2-E     Document Type: Article

References (27)

1. Canick, J.A., Kellner, L.H., Saller, D.N., Palomaki, G.E., Walker, R.P., Osathanondh, R. (1995). Second-trimester levels of maternal urinary gonadotropin peptide in Down syndrome pregnancy, Prenat. Diagn., 15, 739-744.
2. Canick, J.A., Kellner, L.H., Saller, D.N., Palomaki, G.E., Tumber, M.B., Messerlian, G.L., Walker, R.P. (1996). A second level evaluation of maternal urinary gonadotropin peptide as a marker for second trimester Down syndrome screening, Rec. Adv. Prenat. Diagn. Abstract No. 28.
3. Cole, L.A. (1995). Down syndrome screening using urine beta core fragment test: choice of immunoassay, Prenat. Diagn., 15, 679-682.
4. Cole, L.A. (1997). Stability of hCG free beta-subunit and beta-core fragment in urine, Prenat. Diagn., 17, 185-189.
5. Cole, L.A., Kellner, L.H., Isozaki, T., Palomaki, G.E., Iles, R.K., Walker, R.P., Ozaki, M., Canick, J.A. (1997). Comparison of 12 assays for detecting hCG and related molecules in urine samples from Down syndrome pregnancies, Prenat. Diagn., 17, 607-614.
6. Cuckle, H.S., Canick, J.A., Kellner, L.H., Van Lith, J.M.N., White, I., Helbig, B.R., Rose, N.C., Sehmi, I.K., Jones, R. (1996). Urinary beta-core-hCG screening in the first-trimester, Prenat. Diagn., 16, 1057-1059.
7. Cuckle, H.S., Iles, R.K., Chard, T. (1994). Urinary beta-core human chorionic gonadotropin: a new approach to Down's syndrome screening, Prenat. Diagn., 14, 953-958.
8. Cuckle, H.S., Iles, R.K., Sehmi, I.K., Chard, T., Oakley, R.E., Davies, S., Ind, T. (1995). Urinary multiple marker screening for Down's syndrome, Prenat. Diagn., 15, 745-751.
9. Hayashi, M., Kozu, H. (1995). Maternal urinary beta-core fragment of hCG/creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, Prenat. Diagn., 15, 11-16.
10. Hayashi, M., Kozu, H., Takei, H. (1996). Maternal urinary free beta subunit of human chorionic gonadotrophin:creatinine ratios and fetal chromosomal abnormalities in the second trimester of pregnancy, Br. J. Obstet. Gynaecol., 103, 577-580.
11. Isozaki, T., Palomaki, G.E., Bahado-Singh, R.O., Cole, L.A. (1997). Screening for Down syndrome pregnancy using beta-core fragment: prospective study, Prenat. Diagn., 17, 407-413.
12. Knight, G.J., Cole, L.A. (1991). Free beta-subunit hCG measurements: an alternative to hCG for fetal Down syndrome screening, Clin. Chem., 37, 779-782.
13. Kornman, L.H., Morssink, L.P., Wortelboer, M.J.M., Beekhuis, J.R., De Wolf, B.T.H.M., Pratt, J.J., Mantingh, A. (1997). Maternal urinary beta core hCG in chromosomally abnormal pregnancies in the first trimester, Prenat. Diagn., 17, 135-139.
14. Krantz, D., Hallahan, T., Buchanan, P., Larsen, J., Macri, J. (1997). Second trimester detection of trisomy 18 using free beta hCG and AFP, Am. J. Obstet. Gynecol., 176, S90.
15. Macintosh, M.C.M., Nicolaides, K.H., Noble, P., Chard, T., Gunn, L., Iles, R. (1997). Urinary beta core hCG: screening for aneuploidies in early pregnancy (11-14 weeks' gestation), Prenat. Diagn., 17, 401-405.
16. Macri, J.N., Anderson, R.W., Krantz, D.A., Larsen, J.W., Buchanan, P.D. (1996). Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome, Am. J. Obstet. Gynecol., 174, 566-572.
17. Macri, J.N., Spencer, K. (1996). Toward the optimal protocol for Down syndrome screening, Am. J. Obstet. Gynecol., 174, 1668-1669.
18. Macri, J.N., Spencer, K., Garver, K., Buchanan, P.D., Say, B., Carpenter, N.J., Muller, F., Boué, A. (1994). Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome, Prenat. Diagn., 14, 97-103.
19. Muller, F. (1996). See Spencer, K. (1997). hCG and its subunits in first trimester Down Syndrome screening. In: Grudzinskas, J.G., Ward, R.H.T. (Eds). Screening for Down Syndrome in the First Trimester, London: RCOG Press, 126-127.
20. Nicolaides, K.H., Brizot, M.L., Snijders, R.J.M. (1994). Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy, Br. J. Obstet. Gynecol., 101, 782-786.
21. Orlandi, F., Damiani, G., Jakil, M.C., Quartararo, P., Rossi, C., Krantz, D., Macri, J.N. (1996). Lo screening biochimico ED ultrasonografico delle aneuploidie fetali nel primo trimestre di gravidanza, Contraccezione Fertilita Sessualita, 23, 269-273.
22. Spencer, K. (1997). hCG and its subunits in first trimester Down syndrome screening. In: Grudzinskas, J.G., Ward, R.H.T. (Eds). Screening for Down Syndrome in the First Trimester, London: RCOG Press, 117-131.
23. Spencer, K., Aitken, D.A., Macri, J.N., Buchanan, P.D. (1996). Urine free beta hCG and beta core in pregnancies affected by Down's syndrome, Prenat. Diagn., 16, 605-613.
24. Spencer, K., Macri, J.N., Carpenter, P., Anderson, R., Krantz, D.A. (1993). Stability of intact chorionic gonadotropin (hCG) in serum, liquid whole blood, and dried whole-blood filter-paper spots: impact on screening for Down syndrome by measurement of free beta-hCG subunit, Clin. Chem., 39, 1064-1068.
25. Spencer, K., Noble, P., Snijders, R.J.M., Nicolaides, K.H. (1997). First trimester urine free beta hCG, beta core and total oestriol in pregnancies affected by Down's syndrome: implications for first trimester screening with nuchal translucency and serum free beta hCG, Prenat. Diagn., 17, 525-538.
26. Wenstrom, K.D., Owen, J., Chu, D.C., Boots, L. (1997a). Free beta-hCG subunit versus intact hCG in Down syndrome screening, Obstet. Gynecol., 90, 370-374.
27. Wenstrom, K.D., Owen, J., Chu, D.C., Boots, L. (1997b). Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin-A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome, Am. J. Obstet. Gynecol., 177, 987-991.